| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.037 | 0.4 |